PLX SBC to Revenue
Protalix Biotherapeutics Inc · SBC to Revenue
PLX SBC to Revenue
Latest reported2.00%period ending
PLX Quarterly SBC/Revenue (0.00% → 2.00%)
Latest values, visible window
High-resolution chart · PNG
PLX sbc to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 2.0004% | |
| 1.5763% | |
| 8.0246% | |
| 3.35% | |
| 2.727% | |
| 5.3397% | |
| 3.5899% | |
| 3.4523% | |
| 7.4069% | |
| 26.174% | |
| 13.0364% | |
| 10.6042% | |
| 1.2488% | |
| 5.6946% | |
| 6.2551% | |
| 2.9754% | |
| 3.2903% | |
| 5.1974% | |
| 4.8895% | |
| 4.6706% | |
| 8.9933% | |
| 7.2085% | |
| 5.2013% | |
| 13.1047% | |
| 2.4346% | |
| 1.9911% | |
| 1.3289% | |
| 1.3756% | |
| 0.9227% | |
| 2.778% | |
| 1.5471% | |
| 0.1784% | |
| 0.248% | |
| 1.3617% | |
| 1.8631% | |
| 0.9965% | |
| 1.5414% | |
| 4.0845% | |
| 10.716% | |
| 3.4904% | |
| 12.8321% | |
| 55.2283% | |
| -3.4212% | |
| 7.6291% | |
| 41.4671% | |
| 24.7636% | |
| 40.3902% | |
| 2.8595% | |
| -3.4624% | |
| 9.0749% | |
| 56.6845% | |
| 28.4013% | |
| 36.9452% | |
| 34.4506% | |
| 3,512.5% | |
| 42.7829% | |
| 14.3717% | |
| 3.4603% | |
| 6.6046% | |
| 18.4629% | |
| 36.5183% | |
| 4.0333% | |
| 33.5884% | |
| 11.1495% | |
| 21.7353% | |
| 24.8904% | |
| 175.5155% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 2,280.6667% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |